Drug Type Small molecule drug |
Synonyms Alpharen, Macrosorb MD |
Target |
Mechanism Phosphates modulators(Phosphates modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaCH8FeMgO10 |
InChIKeyOFCDMSYSINJNMW-UHFFFAOYSA-F |
CAS Registry119175-48-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Fermagate | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperphosphatemia | Phase 3 | US | 01 Jul 2009 | |
Hyperphosphatemia | Phase 3 | BE | 01 Jul 2009 | |
Hyperphosphatemia | Phase 3 | BR | 01 Jul 2009 | |
Hyperphosphatemia | Phase 3 | BG | 01 Jul 2009 | |
Hyperphosphatemia | Phase 3 | CZ | 01 Jul 2009 | |
Hyperphosphatemia | Phase 3 | EE | 01 Jul 2009 | |
Hyperphosphatemia | Phase 3 | HU | 01 Jul 2009 | |
Hyperphosphatemia | Phase 3 | IL | 01 Jul 2009 | |
Hyperphosphatemia | Phase 3 | IT | 01 Jul 2009 | |
Hyperphosphatemia | Phase 3 | LT | 01 Jul 2009 |
Phase 3 | - | - | Fermagate 1.5 g/d | ntpcnccvhn(rjmfxdwzfo) = 11.6% for F cnezbkqqnl (spiyrwhejp ) View more | Positive | 30 Oct 2012 | |
Sevelamer HCl 2.4 g/d |